NYSE - Nasdaq Real Time Price • USD
Omega Healthcare Investors, Inc. (OHI)
As of 3:01 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 0.32 | 0.34 | 1.37 | 1.46 |
Low Estimate | 0.27 | 0.29 | 1.21 | 1.3 |
High Estimate | 0.36 | 0.36 | 1.52 | 1.65 |
Year Ago EPS | 0.15 | 0.25 | 1 | 1.37 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 6 |
Avg. Estimate | 231.64M | 237.46M | 965.63M | 1.05B |
Low Estimate | 196.2M | 198.3M | 813.6M | 867.6M |
High Estimate | 245.2M | 251.67M | 1.02B | 1.13B |
Year Ago Sales | 215.72M | 231.9M | 949.74M | 965.63M |
Sales Growth (year/est) | 7.40% | 2.40% | 1.70% | 8.50% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.27 | 0.31 | 0.33 | 0.35 |
EPS Actual | 0.15 | 0.25 | 0.37 | 0.22 |
Difference | -0.12 | -0.06 | 0.04 | -0.13 |
Surprise % | -44.40% | -19.40% | 12.10% | -37.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.32 | 0.34 | 1.37 | 1.46 |
7 Days Ago | 0.32 | 0.34 | 1.37 | 1.46 |
30 Days Ago | 0.32 | 0.34 | 1.37 | 1.46 |
60 Days Ago | 0.3 | 0.32 | 1.29 | 1.39 |
90 Days Ago | 0.32 | 0.34 | 1.42 | 1.48 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | OHI | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 113.30% | -- | -- | 0.80% |
Next Qtr. | 36.00% | -- | -- | 9.60% |
Current Year | 37.00% | -- | -- | 4.50% |
Next Year | 6.60% | -- | -- | 13.30% |
Next 5 Years (per annum) | -5.70% | -- | -- | 11.09% |
Past 5 Years (per annum) | -8.19% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Truist Securities: Hold to Hold | 4/2/2024 |
Upgrade | Citigroup: Neutral to Buy | 3/22/2024 |
Upgrade | Wells Fargo: Equal-Weight to Overweight | 2/26/2024 |
Upgrade | Exane BNP Paribas: Underperform to Neutral | 2/8/2024 |
Initiated | Deutsche Bank: Buy | 1/30/2024 |
Downgrade | B of A Securities: Buy to Neutral | 1/16/2024 |
Related Tickers
LTC LTC Properties, Inc.
31.74
+0.79%
SBRA Sabra Health Care REIT, Inc.
13.55
+0.89%
NHI National Health Investors, Inc.
61.16
+1.19%
DOC Healthpeak Properties, Inc.
18.01
0.00%
VTR Ventas, Inc.
42.99
+0.82%
WELL Welltower Inc.
91.04
+0.25%
HR Healthcare Realty Trust Incorporated
13.85
+0.44%
MPW Medical Properties Trust, Inc.
4.4650
-7.75%
GMRE Global Medical REIT Inc.
8.13
+0.06%
UHT Universal Health Realty Income Trust
32.87
+0.56%